AI in drug discovery and its clinical relevance
Rizwan Qureshi(The University of Texas MD Anderson Cancer Center), Tanvir Alam, Muhammad Irfan(Ghulam Ishaq Khan Institute of Engineering Sciences and Technology), Sheheryar Khan(Hong Kong Polytechnic University), John V. Heymach(The University of Texas MD Anderson Cancer Center), Muhammad Usman Hadi(University of Ulster), Taimoor Muzaffar Gondal(Superior University), Jia Wu(The University of Texas MD Anderson Cancer Center), Hong Yan(Regeneron (United States)), Xiuning Le(The University of Texas MD Anderson Cancer Center)
Cited by 271
Related Papers
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
|Nature Medicine|2011|1.4k
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
|Journal of Clinical Oncology|2019|1.3k
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
|The Lancet Oncology|2016|1.1k
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
|Cancer Cell|2021|930
Fuzzy Algorithms: With Applications to Image Processing and Pattern Recognition
|Advances in fuzzy systems|1996|496